In addition, prognostic factors for early recovery: prolonged illness and AIDP Conclusion: The results showed that treatment intravenous immunoglobulin therapy Guilain-Barre syndrome shows that this is a safe and effective treatment, high patient recovery rate after 1 year 100%.